Safety of cox-2 selective nonsteroidal antiinflammatory drugs for postsurgical pain - In response

被引：1

作者：

White, PF ^{[1
]}

机构：

[1] Univ Texas, SW Med Ctr, Dept Anesthesiol & Pain Management, Dallas, TX 75235 USA

来源：

ANESTHESIA AND ANALGESIA | 2006年 / 102卷 / 02期

关键词：

D O I：

10.1213/01.ANE.0000190740.88636.2A

中图分类号：

R614 [麻醉学];

学科分类号：

100217 ;

摘要：

引用

页码：646 / 646

页数：1

共 10 条

[1] Valdecoxib versus rofecoxib in acute postsurgical pain: Results of a randomized controlled trial [J].

Christensen, KS ;

Cawkwell, GD .

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2004, 27 (05) :460-470

[2] A single preoperative oral dose of valdecoxib, a new cyclooxygenase-2 specific inhibitor, relieves post-oral surgery or bunionectomy pain [J].

Desjardins, PJ ;

Shu, VS ;

Recker, DP ;

Verburg, KM ;

Woolf, CJ .

ANESTHESIOLOGY, 2002, 97 (03) :565-573

[3] The injectable cyclooxygenase-2-specific inhibitor parecoxib sodium has analgesic efficacy when administered preoperatively [J].

Desjardins, PJ ;

Grossman, EH ;

Kuss, ME ;

Talwalker, S ;

Dhadda, S ;

Baum, D ;

Hubbard, RC .

ANESTHESIA AND ANALGESIA, 2001, 93 (03) :721-727

[4] Presurgical intravenous parecoxib sodium and follow-up oral valdecoxib for pain management after laparoscopic cholecystectomy surgery reduces opioid requirements and opioid-related adverse effects [J].

Gan, TJ ;

Joshi, GP ;

Zhao, SZ ;

Hanna, DB ;

Cheung, RY ;

Chen, C .

ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2004, 48 (09) :1194-1207

[5] Preoperative parenteral parecoxib and follow-up oral valdecoxib reduce length of stay and improve quality of patient recovery after laparoscopic cholecystectomy surgery [J].

Gan, TJ ;

Joshi, GP ;

Viscusi, E ;

Cheung, RY ;

Dodge, W ;

Fort, JG ;

Chen, C .

ANESTHESIA AND ANALGESIA, 2004, 98 (06) :1665-1673

[6] Effective treatment of laparoscopic cholecystectomy pain with intravenous followed by oral COX-2 specific inhibitor [J].

Joshi, GP ;

Viscusi, ER ;

Gan, TJ ;

Minkowitz, H ;

Cippolle, M ;

Schuller, R ;

Cheung, RY ;

Fort, JG .

ANESTHESIA AND ANALGESIA, 2004, 98 (02) :336-342

[7] Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery [J].

Nussmeier, NA ;

Whelton, AA ;

Brown, MT ;

Langford, RM ;

Hoeft, A ;

Parlow, JL ;

Boyce, SW ;

Verburg, KM .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (11) :1081-1091

[8] Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery [J].

Ott, E ;

Nussmeier, NA ;

Duke, PC ;

Feneck, RO ;

Alston, RP ;

Snabes, MC ;

Hubbard, RC ;

Hsu, PH ;

Saidman, LJ ;

Mangano, DT .

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2003, 125 (06) :1481-1492

[9] Effect of parecoxib, a novel intravenous cyclooxygenase type-2 inhibitor, on the postoperative opioid requirement and quality of pain control [J].

Tang, J ;

Li, ST ;

White, PF ;

Chen, XG ;

Wender, RH ;

Quon, R ;

Sloninsky, A ;

Naruse, R ;

Kariger, R ;

Webb, T ;

Norel, E .

ANESTHESIOLOGY, 2002, 96 (06) :1305-1309

[10] Changing role of COX-2 inhibitors in the Perioperative period: Is parecoxib really the answer? [J].

White, PF .

ANESTHESIA AND ANALGESIA, 2005, 100 (05) :1306-1308

← 1 →